| P50 | author | Ole Lund | Q59198225 |
| | Annemieke Geluk | Q76741543 |
| | Tom H M Ottenhoff | Q87817901 |
| | Kees L M C Franken | Q89400278 |
| | Krista E van Meijgaarden | Q91284128 |
| | Corine Prins | Q97685737 |
| | Gary K Schoolnik | Q114419730 |
| | Igor Kramnik | Q42848268 |
| | Iñaki Comas | Q42777289 |
| P2093 | author name string | Gregory Dolganov | |
| | Susanna Commandeur | |
| | Mariateresa Coppola | |
| | Susan J F van den Eeden | |
| | Fredrik Oftung | |
| | Gro E Korsvold | |
| P2860 | cites work | Tuberculosis: a disease without boundaries | Q26801337 |
| | Tuberculosis vaccine types and timings | Q26862762 |
| | Innovative Strategies to Identify M. tuberculosis Antigens and Epitopes Using Genome-Wide Analyses | Q27027110 |
| | The enduring hypoxic response of Mycobacterium tuberculosis | Q27302134 |
| | Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes | Q27860838 |
| | The complex evolution of antibiotic resistance in Mycobacterium tuberculosis | Q28081874 |
| | Prospects in Mycobacterium bovis Bacille Calmette et Guérin (BCG) vaccine diversity and delivery: why does BCG fail to protect against tuberculosis? | Q28083377 |
| | Quest for correlates of protection against tuberculosis | Q28084282 |
| | Transcriptional Adaptation of Mycobacterium tuberculosis within Macrophages: Insights into the Phagosomal Environment | Q28487339 |
| | Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling | Q28487482 |
| | Ipr1 gene mediates innate immunity to tuberculosis | Q28585986 |
| | Out-of-Africa migration and Neolithic coexpansion of Mycobacterium tuberculosis with modern humans | Q28662322 |
| | Variable host-pathogen compatibility in Mycobacterium tuberculosis | Q28768257 |
| | Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial | Q29620144 |
| | Novel vaccination strategies against tuberculosis. | Q30363188 |
| | Genome-wide profiling identifies epithelial cell genes associated with asthma and with treatment response to corticosteroids | Q30480169 |
| | HLA class I supertypes: a revised and updated classification | Q33315730 |
| | Mycobacterium tuberculosis peptides presented by HLA-E molecules are targets for human CD8 T-cells with cytotoxic as well as regulatory activity | Q33535876 |
| | Clonal analysis of the T-cell response to in vivo expressed Mycobacterium tuberculosis protein Rv2034, using a CD154 expression based T-cell cloning method | Q33721633 |
| | Host cytokine responses induced after overnight stimulation with novel M. tuberculosis infection phase-dependent antigens show promise as diagnostic candidates for TB disease | Q33905078 |
| | Human T cell epitopes of Mycobacterium tuberculosis are evolutionarily hyperconserved | Q33906285 |
| | Protection against Mycobacterium leprae infection by the ID83/GLA-SE and ID93/GLA-SE vaccines developed for tuberculosis | Q34298351 |
| | rBCG30-induced immunity and cross-protection against Mycobacterium leprae challenge are enhanced by boosting with the Mycobacterium tuberculosis 30-kilodalton antigen 85B. | Q34298426 |
| | Immunogenicity of 60 novel latency-related antigens of Mycobacterium tuberculosis | Q34306108 |
| | Variation of Mycobacterium tuberculosis antigen-specific IFN-γ and IL-17 responses in healthy tuberculin skin test (TST)-positive human subjects | Q34374644 |
| | Memory T cells in latent Mycobacterium tuberculosis infection are directed against three antigenic islands and largely contained in a CXCR3+CCR6+ Th1 subset | Q34566079 |
| | Orchestration of pulmonary T cell immunity during Mycobacterium tuberculosis infection: immunity interruptus | Q34603687 |
| | Safety and immunogenicity of H1/IC31®, an adjuvanted TB subunit vaccine, in HIV-infected adults with CD4+ lymphocyte counts greater than 350 cells/mm3: a phase II, multi-centre, double-blind, randomized, placebo-controlled trial | Q34663035 |
| | Human Mycobacterium tuberculosis CD8 T Cell Antigens/Epitopes Identified by a Proteomic Peptide Library | Q34785626 |
| | Effectiveness of routine BCG vaccination on buruli ulcer disease: a case-control study in the Democratic Republic of Congo, Ghana and Togo | Q34875651 |
| | Immunological consequences of intragenus conservation of Mycobacterium tuberculosis T-cell epitopes | Q34985591 |
| | Analysis of host responses to Mycobacterium tuberculosis antigens in a multi-site study of subjects with different TB and HIV infection states in sub-Saharan Africa | Q34989726 |
| | Identification of human T-cell responses to Mycobacterium tuberculosis resuscitation-promoting factors in long-term latently infected individuals | Q35066262 |
| | ESAT-6 (EsxA) and TB10.4 (EsxH) based vaccines for pre- and post-exposure tuberculosis vaccination | Q35069386 |
| | Human CD8+ T-cells recognizing peptides from Mycobacterium tuberculosis (Mtb) presented by HLA-E have an unorthodox Th2-like, multifunctional, Mtb inhibitory phenotype and represent a novel human T-cell subset. | Q35214233 |
| | Longitudinal immune profiles in type 1 leprosy reactions in Bangladesh, Brazil, Ethiopia and Nepal | Q35825015 |
| | Purification of his-tagged proteins by immobilized chelate affinity chromatography: the benefits from the use of organic solvent | Q73386350 |
| | Manipulation of immune responses to Mycobacterium bovis by vaccination with IL-2- and IL-18-secreting recombinant bacillus Calmette Guerin | Q74307645 |
| | Will new tuberculosis vaccines provide protection against leprosy? | Q83159743 |
| | Multifunctional CD4(+) T cells correlate with active Mycobacterium tuberculosis infection | Q44753732 |
| | Progression of pulmonary tuberculosis and efficiency of bacillus Calmette-Guérin vaccination are genetically controlled via a common sst1-mediated mechanism of innate immunity. | Q44778740 |
| | NetMHCcons: a consensus method for the major histocompatibility complex class I predictions | Q44856955 |
| | A novel method of gene transcript profiling in airway biopsy homogenates reveals increased expression of a Na+-K+-Cl- cotransporter (NKCC1) in asthmatic subjects | Q46223311 |
| | Potential of Mycobacterium tuberculosis resuscitation-promoting factors as antigens in novel tuberculosis sub-unit vaccines | Q47990523 |
| | Type VII secretion--mycobacteria show the way. | Q48689947 |
| | WHO's new end TB strategy. | Q50995464 |
| | Double- and monofunctional CD4⁺ and CD8⁺ T-cell responses to Mycobacterium tuberculosis DosR antigens and peptides in long-term latently infected individuals. | Q51001482 |
| | Improved long-term protection against Mycobacterium tuberculosis Beijing/W in mice after intra-dermal inoculation of recombinant BCG expressing latency associated antigens. | Q52893287 |
| | A multistage tuberculosis vaccine that confers efficient protection before and after exposure. | Q54391413 |
| | A Novel MVA-Based Multiphasic Vaccine for Prevention or Treatment of Tuberculosis Induces Broad and Multifunctional Cell-Mediated Immunity in Mice and Primates | Q35849628 |
| | A side-by-side comparison of T cell reactivity to fifty-nine Mycobacterium tuberculosis antigens in diverse populations from five continents | Q36338571 |
| | Antigen Export Reduces Antigen Presentation and Limits T Cell Control of M. tuberculosis | Q36471108 |
| | Analysis of immune responses against a wide range of Mycobacterium tuberculosis antigens in patients with active pulmonary tuberculosis | Q36505201 |
| | Protection and Long-Lived Immunity Induced by the ID93/GLA-SE Vaccine Candidate against a Clinical Mycobacterium tuberculosis Isolate | Q36555077 |
| | M. tuberculosis T Cell Epitope Analysis Reveals Paucity of Antigenic Variation and Identifies Rare Variable TB Antigens | Q36594099 |
| | Functional classification of class II human leukocyte antigen (HLA) molecules reveals seven different supertypes and a surprising degree of repertoire sharing across supertypes | Q36766285 |
| | Identification of human T cell antigens for the development of vaccines against Mycobacterium tuberculosis | Q36982831 |
| | Mycobacterium leprae-induced Insulin-like Growth Factor I attenuates antimicrobial mechanisms, promoting bacterial survival in macrophages | Q36990750 |
| | MHCcluster, a method for functional clustering of MHC molecules | Q37113968 |
| | NetMHCIIpan-3.0, a common pan-specific MHC class II prediction method including all three human MHC class II isotypes, HLA-DR, HLA-DP and HLA-DQ. | Q37257313 |
| | Tuberculosis vaccine with high predicted population coverage and compatibility with modern diagnostics | Q37519663 |
| | New pathways of protective and pathological host defense to mycobacteria | Q38025523 |
| | Genome-based vaccine design: the promise for malaria and other infectious diseases. | Q38246689 |
| | The balance between protective and pathogenic immune responses in the TB-infected lung | Q38293027 |
| | Tuberculosis Comorbidity with Communicable and Noncommunicable Diseases | Q38346780 |
| | T cells and adaptive immunity to Mycobacterium tuberculosis in humans | Q38363792 |
| | Tuberculosis vaccines--state of the art, and novel approaches to vaccine development | Q38391382 |
| | T regulatory cells: Achilles' heel of Mycobacterium tuberculosis infection? | Q38463142 |
| | Interferon gamma release assays for monitoring the response to treatment for tuberculosis: A systematic review | Q38619762 |
| | A review of clinical models for the evaluation of human TB vaccines | Q38711772 |
| | The in vivo expressed Mycobacterium tuberculosis (IVE-TB) antigen Rv2034 induces CD4⁺ T-cells that protect against pulmonary infection in HLA-DR transgenic mice and guinea pigs | Q39190589 |
| | Mycobacterium tuberculosis-specific CD4+ T-cell response is increased, and Treg cells decreased, in anthelmintic-treated patients with latent TB. | Q39531049 |
| | Human T-cell responses to 25 novel antigens encoded by genes of the dormancy regulon of Mycobacterium tuberculosis | Q40239843 |
| | Synthetic Long Peptide Derived from Mycobacterium tuberculosis Latency Antigen Rv1733c Protects against Tuberculosis | Q40706013 |
| | Reprogramming the T Cell Response to Tuberculosis | Q40829662 |
| | Sensitivity of C-Tb: a novel RD-1-specific skin test for the diagnosis of tuberculosis infection | Q40867638 |
| | DosR-regulon genes induction in Mycobacterium bovis BCG under aerobic conditions | Q41004063 |
| | Mycobacterium tuberculosis RpfE promotes simultaneous Th1- and Th17-type T-cell immunity via TLR4-dependent maturation of dendritic cells. | Q41021544 |
| | First-in-human trial of the post-exposure tuberculosis vaccine H56:IC31 in Mycobacterium tuberculosis infected and non-infected healthy adults | Q41148040 |
| | The pleiotropic transcriptional response of Mycobacterium tuberculosis to vitamin C is robust and overlaps with the bacterial response to multiple intracellular stresses | Q41507346 |
| | Dissecting the T Cell Response: Proliferation Assays vs. Cytokine Signatures by ELISPOT. | Q41889499 |
| | Protective CD4 T cells targeting cryptic epitopes of Mycobacterium tuberculosis resist infection-driven terminal differentiation | Q42226870 |
| | An unbiased genome-wide Mycobacterium tuberculosis gene expression approach to discover antigens targeted by human T cells expressed during pulmonary infection | Q42278752 |
| | A multistage-polyepitope vaccine protects against Mycobacterium tuberculosis infection in HLA-DR3 transgenic mice | Q42288785 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Mycobacterium tuberculosis | Q130971 |
| P304 | page(s) | 37793 | |
| P577 | publication date | 2016-11-28 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | New Genome-Wide Algorithm Identifies Novel In-Vivo Expressed Mycobacterium Tuberculosis Antigens Inducing Human T-Cell Responses with Classical and Unconventional Cytokine Profiles | |
| P478 | volume | 6 | |